Pharmaceutical API Powder CAS 1890208-58-8 Compound 7p

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Diamond Member Since 2019

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

to see all verified strength labels (11)
  • Pharmaceutical API Powder CAS 1890208-58-8 Compound 7p
Find Similar Products

Basic Info.

Model NO.
top quality
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Adult
State
Solid
Purity
>99%
CAS No.
1890208-58-8
Molecular Formula
N/a
Molecular Weight
N/a
Appearance
White Powder
Grade Standard
Medicine Grade
MOQ
10g
COA
Pls Contact Senwayer Freely
Storge
2-8 Degree
Exp.
24 Months
Transport Package
1kg/Bag, 25kg/Drum
Specification
MOQ: 100g
Trademark
senwayer
Origin
China
HS Code
2601111000
Production Capacity
50kgs Per Month

Product Description

Nootropics API Compound 7p Powder CAS 1890208-58-8

Pharmaceutical API Powder CAS 1890208-58-8 Compound 7p


Product Introduction

Compound 7p was developed as one in series of compounds with the aim of identifying dual-acting thromboxane receptor
antagonist/synthase inhibitors . In fact compound 7p shows selectivity for prostaglandin I2 synthase (PTGIS , CYP8A1) over thromboxane synthase (CYP5A1).Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential , and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways.
 

Function

Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential , and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways.here we report phenotypic cell-based screen of chemical libraries and structure-activity-guided optimization that resulted in the identification of compound 7p which promotes neurite outgrowth of cultured primary neurons derived from the hippocampus, cerebral cortex, and retina. in an animal model of optic nerve injury, compound 7p was shown to induce growth of gap-43 positive axons, indicating that the in vitro neurite outgrowth activity of compound 7p translates into stimulation of axon regeneration in vivo.further optimization of compound 7p and elucidation of the mechanisms by which it elicits axon regeneration in vivo will provide a rational basis for future efforts to enhance treatment strategies.
 

Other products
 
Beta-Alanine   107-95-9
Creatine monohydrate 6020-87-7 
N,N-dimethylphenylethylamine citrate Eria Jarensis Extract 
L-Glutamine  56-85-9
L Arginine  74-79-3
L-leucine   61-90-5
L-Theanine   3081-61-6
l-citrulline malate 54940-97-5
L-Cysteine  52-90-4 
N-Acetyl-L-Cysteine 616-91-1
L-Tryptophan 73-22-3
L-Serine  56-45-1
creatine hcl  17050-09-8 
agmatine sulfate 2482-00-0 
n acetyl l tyrosine 537-55-3

Pharmaceutical API Powder CAS 1890208-58-8 Compound 7p
Pharmaceutical API Powder CAS 1890208-58-8 Compound 7p
Pharmaceutical API Powder CAS 1890208-58-8 Compound 7p
Pharmaceutical API Powder CAS 1890208-58-8 Compound 7p

Pharmaceutical API Powder CAS 1890208-58-8 Compound 7p
Pharmaceutical API Powder CAS 1890208-58-8 Compound 7p

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier